Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

Non-hydropic intrauterine fetal death more than five months after primary parvovirus B19 infection

  • Margareta Nyman , Lottie Skjöldebrand-Sparre and Kristina Broliden

Abstract

Aims: Clinical follow-up of possible fetal complications associated with maternal parvovirus B19 infection is usually recommended during the 2–3 months after primary infection.

Results: A case of late intrauterine fetal death associated with at least 5 months of maternal parvovirus B19 viremia and in the presence of B19 IgG and IgM is described.

Conclusions: The time of clinical and laboratory followup after maternal parvovirus B19 infection may need to be revised if prolonged viremia is more common than previously described.

:

Corresponding author: Kristina Broliden, Infectious Diseases Unit, F68, Karolinska Institutet, Karolinska University Hospital, Solna, SE-17177 Stockholm/Sweden. Tel.: +46-8-51770000, Fax +46-8-337394, E-mail:

References

1 Corcoran A, BP Mahon, P McParland, A Davoren, S Doyle: Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women. J Med Virol70 (2003) 475Search in Google Scholar

2 Jordan JA, D Huff, JA DeLoia: Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immmunol8 (2001) 288Search in Google Scholar

3 Koch WC, JH Harger, B Barnstein B, SP Adler: Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J17 (1998) 489Search in Google Scholar

4 Miller E, CK Fairley, BJ Cohen, C Seng: Immediate and longterm outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol105 (1998) 174Search in Google Scholar

5 Nonoue T, K Kusuhara, T Hara: Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J21 (2002) 1133Search in Google Scholar

6 O'Malley A, C Barry-Kinsella, C Hughes, P Kelehan, D Devaney, E Mooney, J Gillan: Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr Dev Pathol6 (2003) 414Search in Google Scholar

7 Skjoldebrand L, T Tolfvenstam, N Papadogiannakis, B Wahren, K Broliden, M Nyman: Parvovirus B19 infection: association with third-trimester intrauterine fetal death. Br J Obstet Gynaecol107 (2000) 476Search in Google Scholar

8 Söderlund M, R von Essen, J Haapasaari, U Kiistala, O Kiviluoto, K Hedman: Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet349 (1997) 1063Search in Google Scholar

9 Tolfvenstam T, N Papadogiannakis, O Norbeck, K Petersson, K Broliden: Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet357 (2001) 1494Search in Google Scholar

Published Online: 2005-06-01
Published in Print: 2004-03-01

© Walter de Gruyter

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/JPM.2004.032/html
Scroll to top button